Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

Published:2008-09-15 Issue:6 Volume:113 Page:1332-1337
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Leong Swan Swan,Wee Joseph,Rajan Sandeep,Toh Chee Keong,Lim Wan Teck,Hee Siew Wan,Tay Miah Hiang,Poon Donald,Tan Eng Huat

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099;Al-Sarraf;J Clin Oncol.,1998

2. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against Cancer stage III and IV nasopharyngeal cancer of endemic variety;Wee;J Clin Oncol.,2005

3. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma;Chan;J Natl Cancer Inst.,2005

4. Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results;Zhang;J Clin Oncol.,2005

5. A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma;Au;Ann Oncol.,1994

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin converting enzyme expression on circulating immune cells from colorectal cancer patients correlates with the disease stage. Results from a preliminary study.;2024-07-26

2. Alternative Chemotherapies: Angiotensin-Converting Enzyme Inhibitors Reduce Myeloid-Derived Suppressor Cells to Benefit Older Patients with Colorectal Cancer;Frontiers in Bioscience-Landmark;2023-01-09

3. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma;Cancers;2022-04-11

4. Nasopharyngeal Carcinoma;Pediatric Oncology;2022

5. Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma;Molecular Therapy;2021-02